Articles by Bill Tomson

ItÐs been three months since China announced that it would lift its 13-year ban on U.S. beef, but trade still hasnÐt resumed and the delay is testing the patience of U.S. ranchers.

Several activist groups failed this week in a legal action to ban the USDA from inspecting and allowing foie gras to be sold on the commercial market.

The U.S. is again challenging China in the World Trade Organization, and this time it°s over the country°s failure to import enough wheat, corn and rice to meet its tariff rate quotas.

The U.S. and China have failed in bilateral consultations to resolve a U.S. complaint over Chinese domestic price supports for farmers, setting up the next stage of the dispute with the World Trade Organization (WTO) scheduled to begin the long settlement process.&#

WASHINGTON, Dec. 13, 2016 ` The Obama administration has invested nearly two years into forging new ties with Cuba, and a White House official made the case to reporters Tuesday why the Trump administration should not try to roll back changes.

Donald Trump, Chile, Costa Rica, Finland, Romania, Rwanda, agriculture secretary, Heidi Heitkamp, Kristi Noem, Obamacare, South America, soybean exports, China, Brazil, Argentina, Paraguay, University of Illinois,

Continuing Resolution, USDA Farm Service Agency, California drought relief, Central Valley Project, World Trade Organization, trade restrictions, EPA, China, Mexico, Paris Climate Agreement, Donald Trump, John Block, Agriculture Secretary Tom Vilsack

Too many regulatory agencies around the globe take too long to approve genetically modified plant traits, and the result is lost revenue and curbs on innovation, according to a new report that was commissioned by the U.S. and aimed at China.

CongressP decision to take catfish inspection away from the FDA and give it to USDA was sharply criticized as a waste of money and resources at a House Energy and Commerce subcommittee hearing today in which only one lawmaker dissented.

If China is going to overhaul its agricultural biotechnology approval process, it looks like it will have to happen during the Trump administration, a dubious proposition given the antagonism that the president-elect showed towards China during and after the election campaign.